HSPA1A and urinary bladder cancer: UM-UC10 and UM-UC13 bladder cancer cells express HSPA1A mRNA at a very low level, and treatment with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (Aza) restored HSPA1A expression [28].